Statements in which the resource exists as a subject.
PredicateObject
rdf:type
skos:definition
"The carboxamide resulting from the formal condensation of the aryl amino group of 4-(methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]piperidin-4-amine with propanoic acid." []
skos:inScheme
skos:prefLabel
sufentanil
skos:altLabel
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
skos:notation
ChemIDplus:56030-54-7 "CAS Registry Number", CiteXplore:10628901 "PubMed citation", CiteXplore:10945855 "PubMed citation", CiteXplore:11137863 "PubMed citation", CiteXplore:11504823 "PubMed citation", CiteXplore:15475572 "PubMed citation", CiteXplore:15828831 "PubMed citation", CiteXplore:16621415 "PubMed citation", CiteXplore:17118343 "PubMed citation", CiteXplore:9580589 "PubMed citation", DrugBank:DB00708 "DrugBank", KEGG COMPOUND:56030-54-7 "CAS Registry Number", KEGG COMPOUND:C08022 "KEGG COMPOUND", KEGG DRUG:D05938 "KEGG DRUG", Patent:DE2610228 "Patent", Patent:US3998834 "Patent", Reaxys:499558 "Reaxys Registry Number", Wikipedia:Sufentanil "Wikipedia"
skos:broader
skos:relatedSynonym
sufentanil, sufentanilum, N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide, N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide, Sufentanyl, C22H30N2O2S, CCC(=O)N(c1ccccc1)C1(CCN(CCc2cccs2)CC1)COC, InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3, InChIKey=GGCSSNBKKAUURC-UHFFFAOYSA-N